Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05724498 · ClinicalTrials.gov registry record · NA
Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05724498: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT05724498 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05724498, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Insomnia is a common condition in Veterans, with prevalence rates as high as 53% among treatment-seeking Veterans. Chronic untreated insomnia is associated with increased risk for functional impairment, psychiatric illness, suicidal ideation, unhealthy lifestyles, and decreased quality of life. Cognitive-Behavioral Therapy for Insomnia (CBT-I) is recognized as the first-line treatment for insomnia. Despite its proven efficacy, CBT-I is not always readily provided and/or accessible to Veterans. To address these limitations, behavioral sleep medicine specialists have endeavored to streamline CBT-I through development of time-shortened variations of CBT-I. Although these modifications show promise for advancing care and access, studies comparing brief treatments to standard CBT-I have yet to be performed. This investigation will therefore compare a 4-session brief CBT-I to VA standard 6-session CBT-I to evaluate whether a brief intervention can provide comparable benefits to sleep, functional, and psychiatric outcomes in Veterans with insomnia.
Interventions
- BEHAVIORAL Brief CBT-I
- BEHAVIORAL Standard CBT-I
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05724498
The ClinicalTrials.gov registry entry for NCT05724498 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brief CBT-I is the first listed.
NCT05724498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05724498 about?
NCT05724498 is a clinical study titled "Brief Versus Standard Cognitive Behavioral Therapy for Insomnia in Veterans". Insomnia is a common condition in Veterans, with prevalence rates as high as 53% among treatment-seeking Veterans. Chronic untreated insomnia is associated with increased risk for functional impairment, psychiatric illness, suicidal ideation, unhealthy lifestyles, and decreased quality of life. Cogn...
What is the current status of trial NCT05724498?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2023-05-01. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT05724498?
The interventions under investigation include: Brief CBT-I (BEHAVIORAL), Standard CBT-I (BEHAVIORAL).
Who is sponsoring clinical trial NCT05724498?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.